Member Info for AquaeSulis01

Have to agree to disagree with you on that one Toyin. However, irrespective of the final future sales revenue generated, the mere fact a launch is announced will trigger a major sp upgrade much as the promise of the "revolutionary" psoriasis treatment launch of axisbiotix did for SBTX temporarily.

Bazza, of course PG is entitled to air his views but in this instance they are addressed specifically to elric (not even his BB nomenclature elrico) so why not politely email your complaints direct to the author rather than post it on a general forum like this one?

Beancounting, the annual milestone payment for sweetbiotix pre-launch appears to be $100,000 not ££££s. This can be derived by reviewing the Geographical prebiotix revenue splits in previous FY updates

PG if you want something clarified regarding Lemming articles why don't you privately convey them to Elric by email rather than broadcast on a BB where some subscribe and some not? Similarly, if you have a specific non-market sensitive question that you would like SA to address then you will have three options; wait for the next Investor Meets and submit your question, email Investor Relations at SBTX or pose it through elric to SA.

LWLH can't argue with the historic pedestrian growth but also you cannot ignore the promise and impact that a sweetbiotix launch will have on revenues, profit and share price. Providing the soft launch takes place this year as promised, this share price will fly

Need to keep an eye on profit rather than just revenue "Amazon UK has shown the highest growth rate but has been loss making every month in 2024, reflecting the investment in marketing to grow OptiBiotix's customer base on this platform" so long way to go before breakeven I fancy

Bazzaman, you are obviously one of those people that feel if there is a silence you need to fill the gap with something; sort of suspect the Police relish. The Company now has no need to fundraise to keep the lights on probably ever again, there is still no value assigned to what is looking to be a very astute acquisition despite mounting evidence it will help turn the whole group profitable on its own, and Croda launch details will be announced by October so why fret over tiny price movements in the interim when a multi bagger rise is the most likely outcome here before the Calendar year end?

Dan have an established presence on Pinduodou, product featured has sold 2193 on the site since launch over 2 years ago, with 127 having repeat orders. 20 people have reviewed to say it works.

https://outlook.live.com/mail/0/inbox/id/AQQkADAwATE2MTMwLThhMTYtOTEyYy0wMAItMDAKABAAuKfuj9sglEmovqs0IYlXSQ%3D%3D/sxs/AQMkADAwATE2MTMwLThhMTYtOTEyYy0wMAItMDAKAEYAAAO8aS7HuzFQQKpE9XR4sGpoBwC11FG%2BE5D1Qp65Fs11rTRJAAACAQwAAAC11FG%2BE5D1Qp65Fs11rTRJAAg15ALsAAAAARIAEACbAjwBxUd6SZk3dZ0QUpJM

https://outlook.live.com/mail/0/inbox/id/AQQkADAwATE2MTMwLThhMTYtOTEyYy0wMAItMDAKABAAuKfuj9sglEmovqs0IYlXSQ%3D%3D/sxs/AQMkADAwATE2MTMwLThhMTYtOTEyYy0wMAItMDAKAEYAAAO8aS7HuzFQQKpE9XR4sGpoBwC11FG%2BE5D1Qp65Fs11rTRJAAACAQwAAAC11FG%2BE5D1Qp65Fs11rTRJAAg15ALsAAAAARIAEADz4XwzAnrsQoxz9uQMEmp1

Pheet brand on Amazon in India

https://www.amazon.in/Pheet-Foot-Cream-Rough-Cracked/dp/B0DBR1B8ZJ

Someone selling big

12.625 1,225,000 Unknown* 12.75 13.00 154.66k

Hi Lord, agree that market sensitive information should not be released to individuals and where it has been they would not be allowed to communicate and act on it as they would be "insiders". That said, I think we can also agree that the info released through the Sponsored Lemmings channel does not constitute market sensitive information but that does not mean it is totally irrelevant and of interest to investors and potential investors, after all, as a participant on this BB you obviously enjoy the exchange of ideas and opinions that research by others stimulates.

Regarding the Sponsored Lemmings articles on Opti triggered by non-market sensitive information provided by SOH for dissemination, all I am suggesting is that people leave behind past grudges and use the channel via elrico as an opportunity to ask SOH any questions they have regarding the subject matter with at least some chance of getting a response, after all RNS's, Reach or otherwise and Investor Meets doesn't meet this need.

Nothing wrong with family run businesses, they make up 88% of all businesses in the country, and are often referred to as the backbone of the UK economy. Goodness knows SOH needs help with his comms, still describes himself as a Scientist rather than a Company Director in the Occupation Section of the Company House Filings and anyone who has joined the Investor Meets Presentation knows they have zero chance of having their questions answered through that forum as he just ignores them.

Mol, if you took the blinkers off for s moment you would recognise that Opti now sponsors Lemming Investors as a means of providing communications that do not warrant the cost of a Reach RNS and yet provide colour as to progress being made to both shareholders and the wider investor base that subscribe to Lemmings but are not current Opti shareholders and hence wont read this BB. As a sponsor of course, all Opti related communications are made available free of charge to all so you should embrace this additional comms channel whether you are enthused by the content or not, if nothing else leaving the mudslinging aside, if has stimulated a debate on the merit or other wise of this new product which is a good thing.

In terms of financials from this launch we were told in the Final Results RNS that Opti were " Recruiting four new partners for SlimBiome® in Asia through our partnership with Nutraconnect Pte, all of whom placed initial orders before the end of 2023 and which we expect to contribute revenues of £125,000 to £150,000 in 2024." so part of that. The film star info info provided by Sophie and Dire was interesting, it will certainly help the launch get off to a good start but will have come at a high marketing cost so important that repeat orders flow from it.

Agree that sweetbiotix news is the one all holders crave but that will of course be communicated via a full RNS so rather silly to use it as an example to criticise this latest sponsored piece

With you all the way elrico. Interesting skin biome feature in the May 24 edition of Personal Care that explains the challenges and excitement in using bio-active ingredients in skin care and hence the impact of a clinically proven lysate is likely to have on the market

https://content.yudu.com/web/1u0jl/0A1udfd/PCG-May-2024/html/index.html?page=84&origin=reader

Ah missed that one Toyin, I stand corrected

Opti percentage holding reduction mainly due to the further dilution but comparing the number of shares currently held of 24,940,639 with their last disposal RNS ion 24th Nov 2023 where 25,740,639 shares were held does reveal SOH has sold 800,000 shares under the radar despite declaring he does not need the cash.

Guess we'll find out when they are issued their shares tomorrow

Prompted me to look at last year's May IA presentation slides: forecasts included 2023 soft launch sweetbiotix followed by a full launch 2024, and revenue of near £1.7m for 2023 aided by 3 US launches

Think you're confusing this stock with Kefi where the only investors appear to be Tiddlywink players

Mixed feelings for me. Without this placing then the Company would have been in a "care and maintenance" state waiting for Croda revenues to hopefully kick in, in sufficient quantity to prevent a further fund raise from a potentially very vulnerable position in a worst case scenario. So whilst a further dilution may not have been necessary, this has mitigated the risk associated with the Croda deal.

Also, noting "The additional funding of £1.44m (net of expenses) will enable the Company to continue to support the roll-out of AxisBiotix-Ps, the commercialisation of the acne treatment" the Company can now proceed at pace with these launches and providing we see evidence that this is happening sooner rather than later, then all good. Who knows, perhaps we can add a new revenue stream from Opti by finally enabling their "Q1 2024 Boots launch" using our contacts for a small fee of course? On the Opti note, if our new Investors are that keen to buy into the SBTX story then perhaps they should show willing and buy out Opti's holding in SBTX at the current market price